Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression — Stella

Home/Post Stroke Depression/

View on ClinicalTrials.gov

Recruiting

Back to Post Stroke Depression trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Israel

The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh), Zrifin

Key details

Sponsor

Assaf-Harofeh Medical Center

Enrollment target

~142 participants

Started

November 2023

Primary completion

December 2030

Age range

50 Years – 85 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.